Brind.

United Therapeutics filed disclosures with the Securities and Exchange Commission on June 16, 2026.

1 report, 1 independent Updated Jun 16

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

United Therapeutics Securities and Exchange Commission

Keep exploring

The entities involved

United Therapeutics
biotech company based in Silver Spring, Maryland, United States

Nothing else this week.
Securities and Exchange Commission
government agency of the Philippines
- Defiance S&P 500 Enhanced Options & 0DTE Income ETF filed Form 13F with the SEC.16:52
- FDA completed mid-cycle review of INO-3107, and Inovio Pharmaceuticals announced the appointment of EY as its independent registered public accounting firm.15:13

Coverage

Newest first; wire copies grouped

Jun 16tickerreport.com